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We have studied the regulation of expression of the carbamoyl-phosphate synthetase II-aspartate transcarbamylase-di- 
hydroorotase gene in F9 teratocarcinoma cells during their differentiation into parietal endoderm cells by induction with 
a combination of retinoic acid and dibutyryl cyclic AMP. Steady-state l vels of CAD mRNA decreased by 7-fold in F9 
cells following 120 h of retinoic acid and dibutyryl cyclic AMP induction as compared to levels in uninduced cells. Con- 
versely, no apparent changes were found in the steady-state l vels of &actin mRNA between induced and uninduced 
cells. Despite a 7-fold decrease in the steady-state l vels of CAD mRNA, its rate of transcription remained the same 
between induced and uninduced cells, indicating a role for posttranscriptional mechanisms for its down regulation during 
retinoic acid- and dibutyryl cyclic AMP-induced differentiation of F9 cells. The cellular growth rate of F9 cells as deter- 
mined by PH]thymidine uptake and parallel cell counting decreased markedly during their induction with retinoic acid 
and dibutyryl cyclic AMP. Taken together, it is apparent hat the expression of the CAD gene is cell-growth-dependent 
and its regulation in this system is at the posttranscriptional level. 
CAD gene; mRNA; Enzyme activity; Aspartate transcarbamylase; Cell growth; Differentiation; Pyrimidine 
1. INTRODUCTION 
The de ‘novo pyrimidine biosynthetic pathway 
plays a pivotal role in the supply of pyrimidines for 
nucleic acid biosynthesis. This pathway consists of 
six enzymatic steps, namely carbamoyl-phosphate 
synthetase II (EC 6.3.5.5), aspartate transcar- 
bamylase (EC 2.1.3.2), dihydroorotase (EC 
3.5.2.3), dihydroorotate dehydrogenase (EC 
1.3.99.1 l), orotidylate phosphoribosyltransferase 
(EC 2.4.2.10) and orotidylate decarboxylase (EC 
4.1.1.23) [l]. Fetal tissues have been reported to 
have higher activities of these enzymes than the 
corresponding adult tissues [2-S]. Elevated ac- 
tivities of the enzymes of de novo pyrimidine 
biosynthesis have also been reported in a variety of 
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tumor cells such as Ehrlich ascites [6], hepatoma 
[7] and sarcoma [7]. While these studies revealed a 
positive correlation between the activities of the 
enzymes of de novo pyrimidine biosynthesis and 
cellular growth, the mechanism of its developmen- 
tal regulation is yet to be defined. Based on 
isolated enzymatic and 14COz incorporation 
studies, it was found that the de novo pyrimidine 
biosynthetic pathway is regulated by feedback con- 
trol [&lo]. Even then, it remains unclear par- 
ticularly with respect o the genomic regulation of 
de novo pyrimidine biosynthesis during cellular 
growth. To this end, we have made an attempt to 
study the regulation of expression of the CAD 
gene, which codes for a trifunctional protein in- 
volved in the catalysis of the first three enzymatic 
activities of de novo pyrimidine biosynthesis, 
namely carbamoyl-phosphate synthetase II 
(CPSase), aspartate transcarbamylase (ATCase) 
and dihydroorotase (DHOase) [l 11, in F9 
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teratocarcinoma cells during retinoic acid (RA) 
and dibutyryl cyclic AMP (CAMP) induced dif- 
ferentiation. These cells, upon induction with RA 
and CAMP, cease to proliferate and instead dif- 
ferentiate into parietal endoderm cells [ 12- 141. 
Hence, these cells provide a better model system 
for studying the biological activities associated 
with cellular growth. Here, we report that CAD 
mRNA is reduced substantially during cellular 
growth arrest and its down regulation in this 
system is at the posttranscriptional level. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
Mouse F9 teratocarcinoma cells were provided by Dr Betsy 
Moore of the University of Colorado Health Sciences Center 
(Denver, CO). These cells were grown in Ham’s F12 medium 
supplemented with 15% (v/v) fetal bovine serum. Cultures were 
maintained in humidified 95% air-5% CO2 at 37°C and pas- 
saged at 3-5 x lo5 cells/ml every 3 days. For induction, cells 
were grown for 1 day without inducers in the medium and the 
next day the medium was replaced by fresh medium containing 
inducers, RA (0.3 rg/ml) and CAMP (0.5 mg/ml). Cell viability 
was tested as in [15]. 
2.2. RNA isolation 
Total cellular RNA was isolated from induced and uninduced 
F9 cells by the guanidine isothiocyanate-cesium chloride pro- 
tocol of Chirgwin et al. [16] as described in [15]. Equal amounts 
of total cellular RNA from both induced and uninduced F9 cells 
were size fractionated on 1% agarose containing 6.6% for- 
maldehyde and then transferred to BA85 nitrocellulose filters 
according to Thomas [17]. The filters were baked for 2 h at 
80°C under vacuum and subsequently hybridized to nick- 
translated probes. Nick-translation was carried out with a BRL 
nick-translation kit using [cu-32P]dCTP (spec. act. 3000 Ci/ 
mmol, NEN) essentially as per the supplier’s directions. Details 
of the pCAD142 probe have been published elsewhere [ll]. fi- 
Actin probe (pHF5) [18] was provided by Dr Jerry Woodward 
of the University of Kentucky Medical Center (Lexington, KY). 
Prehybridization, hybridization and washing conditions for the 
filters were the same as those described by Meinkoth and Wahl 
P91. 
2.3. Transcription assay 
Nuclei from both induced and uninduced F9 cells were 
isolated according to Groudine et al. [20]. RNA labeling in 
isolated nuclei using [cx-~~P]UTP (spec. act. 3000 Ci/mmol, 
NEN) and its further isolation and purification were performed 
as described by Linial et al. [21]. Hybridization of labeled RNA 
transcripts to the gene DNAs immobilized on BA85 
nitrocellulose filters and subsequent washings were performed 
according to Linial et al. [21]. 
2.4. ATCase assay 
ATCase activity in induced and uninduced F9 cells was 
measured by the method of Shoaf and Jones [l] using 
[UL4C]aspartate (spec. act. 231 mCi/mmol, NEN) as one of its 
substrates. Enzyme activity is expressed as nmol N-carbamoyl 
L-aspartate formed/mg protein per min. Protein content was 
determined according to Bradford [22]. 
2.5. DNA synthesis 
Cells with and without an appropriate period of induction 
with RA and CAMP were labeled for 1 h by incubation at 37°C 
in medium containing 1 &i/ml of [methyl-‘Hlthymidine (spec. 
act. 78.3 Ci/mmol, NEN). Cells were then collected by a brief 
trypsinization and centrifugation. The cell pellet was washed 
once with 10 ml cold phosphate-buffered saline (PBS). The 
final cell pellet was resuspended in 1 ml cold PBS and an equal 
volume of 20% (w/v) ice-cold trichloroacetic acid was added to 
it and left on ice for 10 min. Collection of trichloroacetic acid- 
precipitable material and radioactivity counting were as de- 
scribed [15]. 
3. RESULTS AND DISCUSSION 
The growth rate of F9 cells was determined by 
[3H]thymidine uptake into DNA and by parallel 
cell counting at various intervals after initiation of 
induction with RA and CAMP. As shown in fig.1, 
the growth rate of F9 cells after 24 and 48 h of RA 
and CAMP induction did not change significantly 
as compared to that of uninduced cells. However, 
following 72 h of induction with RA and CAMP, 
the cells showed a markedly decreased growth rate. 
These decreases in F9 cell growth rates were even 
more prominent after 96 and 120 h of induction 
with RA and CAMP (fig.1). Our results on F9 cell 
growth rate during the course of RA and CAMP in- 
duction are in excellent agreement with those of 
Campisi et al. [14]. The viability of F9 cells even 
after prolonged periods of induction with RA and 
CAMP (in this case 120 h) was above 90%. Fur- 
thermore, these cells had a protein synthetic activi- 
ty, as determined by [r4C]leucine uptake into 
trichloroacetic acid-precipitable proteins, of 80% 
of that of uninduced cells. 
In order to study the regulation of expression of 
the CAD gene during cell growth, steady-state 
levels of CAD mRNA were determined in F9 cells 
at various intervals of exponential growth and time 
points after the initiation of induction with RA 
and CAMP. Steady-state levels of CAD mRNA in 
uninduced exponentially growing F9 cells were not 
affected significantly during the experimental 
period (not shown). As shown in fig.2, no signifi- 
cant changes were observed in the steady-state 
levels of CAD mRNA in 24 and 48 h RA- and 
CAMP-induced cells as compared to levels in unin- 
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Fig. 1. Growth rate of F9 teratocarcinoma cells in the presence 
and absence of the inducers, RA and CAMP. 
duced cells. However, at 72 to 120 h of induction 
with RA and CAMP, the respective steady-state 
levels of CAD mRNA decreased by 3- and 7-fold 
vs levels in uninduced F9 cells (fig.2). On the other 
hand, when the Northern blot was reprobed with 
,&actin probe, no differences were found in its 
steady-state mRNA levels between induced and 
uninduced cells. In fact, a slight increase in mRNA 
content was observed in cells induced for 96 and 
120 h (fig.3). This result indicates that decreased 
CAD mRNA levels in induced F9 cells are not due 
to a general effect of the inducers but specifically 
reflect the decreased cellular growth rate. The 
decreases in CAD mRNA steady-state levels from 
72 to 120 h of RA and CAMP induction are in ac- 
cordance with the decreased cellular growth rates 
observed at those time points of induction. This 
positive correlation between decreased CAD 
steady-state mRNA levels and decreased cellular 
growth rates suggests that CAD gene expression is 
linked to cellular proliferation. Another line of 
evidence in support of CAD gene expression being 
linked to cellular proliferation comes from ex- 
periments using BALB/c 3T3 cells. When these 
cells were synchronized by serum deprivation and 
then stimulated with serum, CAD steady-state 
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Fig.2. Northern blot analysis of CAD mRNA. Equal amounts 
of total ceilular RNA (40 rg/lane) from exponentially growing 
(lane 1) and from 24, 48, 72, 96 and 120 h RA- and CAMP- 
induced F9 cells (lanes 2-6, .respectively) were fractionated 
electrophoretically on agarose-formaldehyde g l, transferred to 
nitrocellulose filters and hybridized with nick-translated 
pCAD142 DNA. 
mRNA levels increased IO-fold (Rao and Church, 
unpublished). 
To delineate the mechanism for the down 
regulation of CAD steady-state mRNA levels in in- 
duced F9 cells, nuclei were isolated from 120 h 
RA- and CAMP-induced cells and from exponen- 
tially growing cells (48 h after seeding), followed 
by performing nuclear run-off assays. At these 
time points the densities of induced and uninduced 
F9 cells were about the same (6-8 x lo5 cells/ml) 
but steady-state CAD mRNA levels differ from 
each other by a factor of 7. The nuclear run-off 
assay determines the number of nuclear transcripts 
present on the chromatin for a particular gene at a 
given time. Nuclear transcripts initiated in vivo 
and elongated in vitro were hybridized to CAD and 
&actin DNAs immobilized on nitrocellulose filters 
(fig.4). Note that the rate of CAD gene transcrip- 
tion between 120 h RA- and CAMP-induced and 
uninduced F9 cells was unchanged. The rate of ,8- 
actin gene transcription between induced and unin- 
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Fig.3. Northern blot analysis of fl-actin mRNA. The Northern 
blots which were used for pCAD142 probing were reprobed 
with b-actin probe, pHF5, as described in section 2. 
duced F9 cells also remained unchanged, which in 
fact agrees with its steady-state mRNA levels. It is 
most unlikely that the nuclear run-off signals with 
CAD and &actin DNAs are artifactual, since no 
hybridization signals were observed with control 
pBR322 DNA (fig.4). At the same time, when the 
nuclear transcripts were isolated in the presence of 
Ly-amanitin, a potent inhibitor of RNA polymerase 
II activity, and hybridized to CAD and &actin 
gene DNAs, no signals were found (not shown). 
This result further indicates that the transcripts 
hybridized to CAD and /?-actin gene DNAs are 
RNA polymerase II activity dependent. The 
decreased steady-state CAD mRNA levels in in- 
duced F9 cells compared to the unaltered rate of its 
transcription between induced and uninduced cells 
suggests a role for posttranscriptional mechanisms 
such as RNA processing or RNA stability during 
RA- and CAMP-induced differentiation of F9 
cells. However, previously we [15] and Lio et al. 
[23] reported a down regulation of CAD gene in 
terminally differentiating HL-60 cells and in 
serum-starved Syrian hamster cells, respectively. 
We [15] and Liao et al. [23] have further reported 
that the down regulation of the CAD gene in those 
pBR-322 - 
CAD - 
Actin - 
Fig.4. Transcriptional analysis of CAD alnd ,%actin gene-s in 
exponentially growing (lane 1) and 120 h RA- and CAMP- 
induced (lane 2) F9 cells. 
systems is due to a parallel decrease in its transcrip- 
tion rate. Although the present and previous 
studies [15,23] clearly demonstrate a down regula-’ 
tion of the CAD gene during cellular growth ar- 
rest, it appears that the mechanisms responsible 
for its down regulation vary among different cell 
types. This type of regulation may not be unique to 
the CAD gene alone, since such types of regulation 
have also been reported for other genes such as 
thymidine kinase [24-261, dihydrofolate reductase 
[27-291, and c-myc [21,30]. For example, in the 
case of c-myc, transcriptional mechanisms were 
reported for its down regulation in differentiating 
HL-60 cells [21] whereas posttranscriptional 
mechanisms were described for its down regulation 
in differentiating F9 cells [30]. 
ATCase activity was used as a general marker of 
the three enzymes associated with CAD protein. Its 
activity in 120 h RA- and CAMP-induced F9 cells 
decreased by 50% vs uninduced cells (table 1). This 
is a relatively small decrease in ATCase activity as 
compared to the 7-fold decrease in its message con- 
tent in induced cells, which could be due to a long 
half-life of CAD protein in F9 cells. A half-life of 
75 h for the CAD protein was reported in Syrian 
hamster cells [31]. Our results on CAD mRNA 
levels and ATCase activity in F9 cells during induc- 
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Table 1 
ATCase activity in F9 teratocarcinoma cells during RA- and 
CAMP-induced differentiation 
Induction time (h) ATCase activity 
0 11.62 
24 12.46 
48 11.37 
72 10.86 
96 8.12 
120 5.68 
ATCase activity is expressed as nmol N-carbamoyl L-aspartate 
formed/mg protein per min 
tion with RA and CAMP are in agreement with 
those of Liao et al. [23] in serum-starved Syrian 
hamster cells. 
The down regulation of the CAD gene in dif- 
ferentiating F9 cells (present findings) and dif- 
ferentiating HL-60 cells [15] together with the 
previously observed positive correlation between 
the activities of the enzymes associated with the 
CAD gene and the degree of cellular growth [2-71 
strongly support our hypothesis that the de novo 
pyrimidine biosynthetic activity is linked to cellular 
proliferation. Since CPSase is the first and rate- 
limiting enzyme of de novo pyrimidine biosyn- 
thesis in higher eukaryotes and one of the three en- 
zymes encoded by the CAD gene, it is clear from 
the above findings that de novo pyrimidine biosyn- 
thesis during cellular growth is regulated by 
modulating the synthesis of its rate-limiting en- 
zyme, CPSase. 
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